Syngenta Expands Botanical Biofungicide Deal with BSI Across Americas
Event summary
- Syngenta and Botanical Solution Inc. (BSI) expanded their exclusive agreement to distribute Quillibrium®, a botanical-based biofungicide, across Mexico, Canada, and the United States.
- Quillibrium®, derived from Quillaja saponaria, has shown successful results in protecting crops like grapes, tomatoes, and berries from diseases such as Botrytis and Powdery Mildew in Chile and Peru since 2021.
- The biofungicide is produced using BSI’s proprietary plant tissue culture platform, ensuring consistent, high-quality extracts without harming protected trees.
- Syngenta aims to enhance farmers’ access to sustainable biocontrol solutions, supporting integrated pest management (IPM) strategies.
The big picture
Syngenta’s expansion of the Quillibrium® agreement with BSI aligns with the growing trend towards sustainable agricultural solutions. The biologicals market is projected to exceed $20 billion by 2030, and Syngenta is positioning itself as a leader in this space by integrating nature-inspired solutions that offer both profitability and resilience for farmers. This move underscores the strategic shift towards biocontrol solutions in crop protection, reflecting broader industry dynamics favoring eco-friendly practices.
What we're watching
- Market Adoption
- How quickly Quillibrium® will be adopted by farmers in North America, given its successful track record in South America.
- Regulatory Compliance
- Whether the biofungicide will face any regulatory hurdles in new markets, potentially affecting its distribution timeline.
- Competitive Positioning
- The pace at which Syngenta can leverage this expansion to strengthen its leadership in the biologicals market, projected to exceed $20 billion by 2030.
Related topics